Collateral for a security interest recorded Aug 25, 2022 (Midcap Financial Trust).
Lapsed Jul 22, 2026 on the fee record · High confidence
20-year base term ends Apr 22, 2029
Third maintenance fee unpaid; grace period ended.
Held by Rigel Pharmaceuticals, Inc.
Filed Sep 18, 2012 as application 13/622,078 · Granted Jul 22, 2014
Base term, 20 years from filing, plus 84 days of patent term adjustment (USPTO delay)
Today
Lapsed Jul 22, 2026
2009
2029
Clock starts
Apr 22, 2009
Apr 22, 2009
No longer in force
Jul 22, 2026
Jul 22, 2026
Granted
Jul 22, 2014
Jul 22, 2014
Term would have run to
Jul 15, 2029
Jul 15, 2029
base term
patent term adjustment
after the term ends
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
84
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,314,107, to Jul 15, 2029. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
Its term would have run to Jul 15, 2029: its 20-year base term plus 84 days of term adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 22, 2009, when application 12/428,334, the earliest non-provisional in its chain, was filed (this one was filed Sep 18, 2012) | Apr 22, 2029 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +84 days, USPTO patent term adjustment record | Jul 15, 2029 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,314,107) | resolves to Jul 15, 2029, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | lapsed Jul 22, 2026 | High confidence |
| Computed term end | The steps above, in order | Jul 22, 2026 | High confidence |
This family
| US 8,314,107 | Lapsed on the fee record Nov 2024 | Nov 2024 |
| US 8,785,449 | this patent Jul 2026 | Jul 2026 |
| US 8,871,770 | Grace period ended Apr 2029 | Apr 2029 |
| US 9,062,052 | In force Apr 2029 | Apr 2029 |
| US 9,255,085 | In force Apr 2029 | Apr 2029 |
| US 9,353,111 | In force Apr 2029 | Apr 2029 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 25, 2012 Reel 29193, frame 580 | Yu, Jiaxin; Hong, Hui; Darwish, Ihab S.; Xu, Xiang; Singh, Rajinder | Rigel Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Aug 25, 2022 Reel 61327, frame 712 | Rigel Pharmaceuticals, Inc. | Midcap Financial Trust | Security Interest |
| May 8, 2026 Reel 75576, frame 880 | Rigel Pharmaceuticals, Inc. | Midcap Funding IV Trust | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 84 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,314,107, ends no earlier than this term, so it caps nothing.
Citations
6
later US patents cite this one
That is below the median of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.